Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Belite Bio, Inc. Sponsored ADR (BLTE) had Non-Operating Income/Expense of $6.55M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-28.41M |
|
-- |
|
-- |
|
$34.91M |
|
$-34.91M |
|
|
Non-Operating Income/Expense |
$6.55M |
$-28.36M |
|
$-28.36M |
|
$-28.41M |
|
$-28.41M |
|
$-28.41M |
|
$-28.41M |
|
$-34.91M |
|
$-34.91M |
|
40.18M |
|
40.18M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$501.60M |
|
-- |
|
$289.98M |
|
$791.58M |
|
$14.95M |
|
-- |
|
-- |
|
$14.95M |
|
-- |
|
$776.64M |
|
$776.64M |
|
40.27M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.66% |
|
-3.59% |
|
-3.66% |
|
$19.28 |
|
-- |
|
-- |
|